Clinical utility of circulating tumor DNA (ctDNA) in resectable pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Wong, Hui-Li
Bushell, Kevin
Karasinska, Joanna
Arthur, Sarah
Morin, Ryan
Schaeffer, David F.
Renouf, Daniel John
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] Simon Fraser Univ, Vancouver, BC, Canada
[3] Pancreas Ctr BC, Vancouver, BC, Canada
[4] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada
[5] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.247
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
247
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Lee, Jee-Soo
    Rhee, Tae-Min
    Pietrasz, Daniel
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    Kong, Sun-Young
    Takai, Erina
    Yachida, Shinichi
    Shibata, Tatsuhiro
    Lee, Jung Woo
    Park, Hyoung-chul
    Zang, Dae Young
    Jeon, Kibum
    Lee, Jiwon
    Kim, Miyoung
    Kim, Han-Sung
    Kang, Hee Jung
    Lee, Young Kyung
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] Assessment of mutation burden after clinical intervention in pancreatic ductal adenocarcinomas (PDAC), and biliary tract cancers (BTC) via profiling circulating tumor DNA (ctDNA).
    Pittella-Silva, Fabio
    Motoya, Masayo
    Kimura, Yasutoshi
    Nakamura, Toru
    Low, Siew-Kee Kee
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).
    Shahda, Safi
    Perkins, Susan
    Cramer, Harvey M.
    House, Michael Garrett
    Nakeeb, Attila
    Zyromski, Nicholas J.
    Ceppa, Eugene P.
    Sehdev, Amikar
    Akisik, Fatih
    Lin, Jingmei
    Schmidt, Christian
    Ellsworth, Susannah G.
    O'Neil, Nina
    Link, Kristen
    O'Neil, Bert
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
    Freed, Ian M.
    Kasi, Anup
    Fateru, Oluwadamilola
    Hu, Mengjia
    Gonzalez, Phasin
    Weatherington, Nyla
    Pathak, Harsh
    Hyter, Stephen
    Sun, Weijing
    Al-Rajabi, Raed
    Baranda, Joaquina
    Hupert, Mateusz L.
    Chalise, Prabhakar
    Godwin, Andrew K.
    Witek, Malgorzata A.
    Soper, Steven A.
    CELLS, 2023, 12 (18)
  • [25] Early detection of pancreatic ductal adenocarcinoma (PDAC) using methylation signatures in circulating tumour DNA
    Liu, X.
    He, Q.
    Su, Z.
    Guo, S.
    Liang, Z.
    Jin, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S792 - S792
  • [26] Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Alqahtani, Ali
    Alloghbi, Abdurahman
    Coffin, Philip
    Yin, Chao
    Mukherji, Reetu
    Weinberg, Benjamin A.
    SURGICAL ONCOLOGY-OXFORD, 2023, 51
  • [27] Development of PCR assays to detect signature circulating tumor DNA methylation markers and KRas mutations for pancreatic ductal adenocarcinoma (PDAC)
    Guo, Shiwei
    Su, Mingyang
    Shi, Xiaohan
    Gao, Suizhi
    Wang, Huan
    Pan, Yaqi
    Gong, Chengxiang
    He, Qiye
    Liu, Rui
    Jin, Gang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [28] LEClinical Utility of Comprehensive Sequencing of Circulating Tumor DNA in Resectable Pancreatic Cancer
    Imamura, Taisuke
    Ashida, Ryo
    Sugiura, Teiichi
    Ohgi, Katsuhisa
    Yamada, Mihoko
    Otsuka, Shimpei
    Uesaka, Katsuhiko
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S285 - S285
  • [29] Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
    Tyerman, Zachary
    Ambler, Emily
    Schlick, Cary Jo R.
    Nwajei, Felix
    Chawla, Akhil
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [30] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
12345